Global Endometriosis Therapies Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Therapies used to treat endometriosis include: Hormonal contraceptives. Birth control pills, patches and vaginal rings help control the hormones responsible for the buildup of endometrialtissue each month
LPI (LP Information)' newest research report, the “Endometriosis Therapies Industry Forecast” looks at past sales and reviews total world Endometriosis Therapies sales in 2022, providing a comprehensive analysis by region and market sector of projected Endometriosis Therapies sales for 2023 through 2029. With Endometriosis Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Endometriosis Therapies industry.
This Insight Report provides a comprehensive analysis of the global Endometriosis Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Endometriosis Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Endometriosis Therapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Endometriosis Therapies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Endometriosis Therapies.
The global Endometriosis Therapies market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Endometriosis Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Endometriosis Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Endometriosis Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Endometriosis Therapies players cover AbbVie, Eli Lilly, AstraZeneca, Bayer, Astellas Pharma, Meditrina Pharmaceuticals, Pfizer, Neurocrine Biosciences and Takeda Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Endometriosis Therapies market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Therapies used to treat endometriosis include: Hormonal contraceptives. Birth control pills, patches and vaginal rings help control the hormones responsible for the buildup of endometrialtissue each month
LPI (LP Information)' newest research report, the “Endometriosis Therapies Industry Forecast” looks at past sales and reviews total world Endometriosis Therapies sales in 2022, providing a comprehensive analysis by region and market sector of projected Endometriosis Therapies sales for 2023 through 2029. With Endometriosis Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Endometriosis Therapies industry.
This Insight Report provides a comprehensive analysis of the global Endometriosis Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Endometriosis Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Endometriosis Therapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Endometriosis Therapies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Endometriosis Therapies.
The global Endometriosis Therapies market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Endometriosis Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Endometriosis Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Endometriosis Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Endometriosis Therapies players cover AbbVie, Eli Lilly, AstraZeneca, Bayer, Astellas Pharma, Meditrina Pharmaceuticals, Pfizer, Neurocrine Biosciences and Takeda Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Endometriosis Therapies market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Hormonal Contraceptives
- Gonadotropin-releasingHormone(Gn-RH)Agonists
- Progestin Therapy
- Aromatase Inhibitors
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- Eli Lilly
- AstraZeneca
- Bayer
- Astellas Pharma
- Meditrina Pharmaceuticals
- Pfizer
- Neurocrine Biosciences
- Takeda Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Endometriosis Therapies Market Size 2018-2029
2.1.2 Endometriosis Therapies Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Endometriosis Therapies Segment by Type
2.2.1 Hormonal Contraceptives
2.2.2 Gonadotropin-releasingHormone(Gn-RH)Agonists
2.2.3 Progestin Therapy
2.2.4 Aromatase Inhibitors
2.3 Endometriosis Therapies Market Size by Type
2.3.1 Endometriosis Therapies Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Endometriosis Therapies Market Size Market Share by Type (2018-2023)
2.4 Endometriosis Therapies Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Endometriosis Therapies Market Size by Application
2.5.1 Endometriosis Therapies Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Endometriosis Therapies Market Size Market Share by Application (2018-2023)
3 ENDOMETRIOSIS THERAPIES MARKET SIZE BY PLAYER
3.1 Endometriosis Therapies Market Size Market Share by Players
3.1.1 Global Endometriosis Therapies Revenue by Players (2018-2023)
3.1.2 Global Endometriosis Therapies Revenue Market Share by Players (2018-2023)
3.2 Global Endometriosis Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ENDOMETRIOSIS THERAPIES BY REGIONS
4.1 Endometriosis Therapies Market Size by Regions (2018-2023)
4.2 Americas Endometriosis Therapies Market Size Growth (2018-2023)
4.3 APAC Endometriosis Therapies Market Size Growth (2018-2023)
4.4 Europe Endometriosis Therapies Market Size Growth (2018-2023)
4.5 Middle East & Africa Endometriosis Therapies Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Endometriosis Therapies Market Size by Country (2018-2023)
5.2 Americas Endometriosis Therapies Market Size by Type (2018-2023)
5.3 Americas Endometriosis Therapies Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Endometriosis Therapies Market Size by Region (2018-2023)
6.2 APAC Endometriosis Therapies Market Size by Type (2018-2023)
6.3 APAC Endometriosis Therapies Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Endometriosis Therapies by Country (2018-2023)
7.2 Europe Endometriosis Therapies Market Size by Type (2018-2023)
7.3 Europe Endometriosis Therapies Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Endometriosis Therapies by Region (2018-2023)
8.2 Middle East & Africa Endometriosis Therapies Market Size by Type (2018-2023)
8.3 Middle East & Africa Endometriosis Therapies Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ENDOMETRIOSIS THERAPIES MARKET FORECAST
10.1 Global Endometriosis Therapies Forecast by Regions (2024-2029)
10.1.1 Global Endometriosis Therapies Forecast by Regions (2024-2029)
10.1.2 Americas Endometriosis Therapies Forecast
10.1.3 APAC Endometriosis Therapies Forecast
10.1.4 Europe Endometriosis Therapies Forecast
10.1.5 Middle East & Africa Endometriosis Therapies Forecast
10.2 Americas Endometriosis Therapies Forecast by Country (2024-2029)
10.2.1 United States Endometriosis Therapies Market Forecast
10.2.2 Canada Endometriosis Therapies Market Forecast
10.2.3 Mexico Endometriosis Therapies Market Forecast
10.2.4 Brazil Endometriosis Therapies Market Forecast
10.3 APAC Endometriosis Therapies Forecast by Region (2024-2029)
10.3.1 China Endometriosis Therapies Market Forecast
10.3.2 Japan Endometriosis Therapies Market Forecast
10.3.3 Korea Endometriosis Therapies Market Forecast
10.3.4 Southeast Asia Endometriosis Therapies Market Forecast
10.3.5 India Endometriosis Therapies Market Forecast
10.3.6 Australia Endometriosis Therapies Market Forecast
10.4 Europe Endometriosis Therapies Forecast by Country (2024-2029)
10.4.1 Germany Endometriosis Therapies Market Forecast
10.4.2 France Endometriosis Therapies Market Forecast
10.4.3 UK Endometriosis Therapies Market Forecast
10.4.4 Italy Endometriosis Therapies Market Forecast
10.4.5 Russia Endometriosis Therapies Market Forecast
10.5 Middle East & Africa Endometriosis Therapies Forecast by Region (2024-2029)
10.5.1 Egypt Endometriosis Therapies Market Forecast
10.5.2 South Africa Endometriosis Therapies Market Forecast
10.5.3 Israel Endometriosis Therapies Market Forecast
10.5.4 Turkey Endometriosis Therapies Market Forecast
10.5.5 GCC Countries Endometriosis Therapies Market Forecast
10.6 Global Endometriosis Therapies Forecast by Type (2024-2029)
10.7 Global Endometriosis Therapies Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Endometriosis Therapies Product Offered
11.1.3 AbbVie Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Information
11.2.2 Eli Lilly Endometriosis Therapies Product Offered
11.2.3 Eli Lilly Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Eli Lilly Main Business Overview
11.2.5 Eli Lilly Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Endometriosis Therapies Product Offered
11.3.3 AstraZeneca Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Endometriosis Therapies Product Offered
11.4.3 Bayer Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 Astellas Pharma
11.5.1 Astellas Pharma Company Information
11.5.2 Astellas Pharma Endometriosis Therapies Product Offered
11.5.3 Astellas Pharma Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Astellas Pharma Main Business Overview
11.5.5 Astellas Pharma Latest Developments
11.6 Meditrina Pharmaceuticals
11.6.1 Meditrina Pharmaceuticals Company Information
11.6.2 Meditrina Pharmaceuticals Endometriosis Therapies Product Offered
11.6.3 Meditrina Pharmaceuticals Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Meditrina Pharmaceuticals Main Business Overview
11.6.5 Meditrina Pharmaceuticals Latest Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer Endometriosis Therapies Product Offered
11.7.3 Pfizer Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Pfizer Main Business Overview
11.7.5 Pfizer Latest Developments
11.8 Neurocrine Biosciences
11.8.1 Neurocrine Biosciences Company Information
11.8.2 Neurocrine Biosciences Endometriosis Therapies Product Offered
11.8.3 Neurocrine Biosciences Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Neurocrine Biosciences Main Business Overview
11.8.5 Neurocrine Biosciences Latest Developments
11.9 Takeda Pharmaceutical
11.9.1 Takeda Pharmaceutical Company Information
11.9.2 Takeda Pharmaceutical Endometriosis Therapies Product Offered
11.9.3 Takeda Pharmaceutical Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Takeda Pharmaceutical Main Business Overview
11.9.5 Takeda Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Endometriosis Therapies Market Size 2018-2029
2.1.2 Endometriosis Therapies Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Endometriosis Therapies Segment by Type
2.2.1 Hormonal Contraceptives
2.2.2 Gonadotropin-releasingHormone(Gn-RH)Agonists
2.2.3 Progestin Therapy
2.2.4 Aromatase Inhibitors
2.3 Endometriosis Therapies Market Size by Type
2.3.1 Endometriosis Therapies Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Endometriosis Therapies Market Size Market Share by Type (2018-2023)
2.4 Endometriosis Therapies Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Endometriosis Therapies Market Size by Application
2.5.1 Endometriosis Therapies Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Endometriosis Therapies Market Size Market Share by Application (2018-2023)
3 ENDOMETRIOSIS THERAPIES MARKET SIZE BY PLAYER
3.1 Endometriosis Therapies Market Size Market Share by Players
3.1.1 Global Endometriosis Therapies Revenue by Players (2018-2023)
3.1.2 Global Endometriosis Therapies Revenue Market Share by Players (2018-2023)
3.2 Global Endometriosis Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ENDOMETRIOSIS THERAPIES BY REGIONS
4.1 Endometriosis Therapies Market Size by Regions (2018-2023)
4.2 Americas Endometriosis Therapies Market Size Growth (2018-2023)
4.3 APAC Endometriosis Therapies Market Size Growth (2018-2023)
4.4 Europe Endometriosis Therapies Market Size Growth (2018-2023)
4.5 Middle East & Africa Endometriosis Therapies Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Endometriosis Therapies Market Size by Country (2018-2023)
5.2 Americas Endometriosis Therapies Market Size by Type (2018-2023)
5.3 Americas Endometriosis Therapies Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Endometriosis Therapies Market Size by Region (2018-2023)
6.2 APAC Endometriosis Therapies Market Size by Type (2018-2023)
6.3 APAC Endometriosis Therapies Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Endometriosis Therapies by Country (2018-2023)
7.2 Europe Endometriosis Therapies Market Size by Type (2018-2023)
7.3 Europe Endometriosis Therapies Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Endometriosis Therapies by Region (2018-2023)
8.2 Middle East & Africa Endometriosis Therapies Market Size by Type (2018-2023)
8.3 Middle East & Africa Endometriosis Therapies Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ENDOMETRIOSIS THERAPIES MARKET FORECAST
10.1 Global Endometriosis Therapies Forecast by Regions (2024-2029)
10.1.1 Global Endometriosis Therapies Forecast by Regions (2024-2029)
10.1.2 Americas Endometriosis Therapies Forecast
10.1.3 APAC Endometriosis Therapies Forecast
10.1.4 Europe Endometriosis Therapies Forecast
10.1.5 Middle East & Africa Endometriosis Therapies Forecast
10.2 Americas Endometriosis Therapies Forecast by Country (2024-2029)
10.2.1 United States Endometriosis Therapies Market Forecast
10.2.2 Canada Endometriosis Therapies Market Forecast
10.2.3 Mexico Endometriosis Therapies Market Forecast
10.2.4 Brazil Endometriosis Therapies Market Forecast
10.3 APAC Endometriosis Therapies Forecast by Region (2024-2029)
10.3.1 China Endometriosis Therapies Market Forecast
10.3.2 Japan Endometriosis Therapies Market Forecast
10.3.3 Korea Endometriosis Therapies Market Forecast
10.3.4 Southeast Asia Endometriosis Therapies Market Forecast
10.3.5 India Endometriosis Therapies Market Forecast
10.3.6 Australia Endometriosis Therapies Market Forecast
10.4 Europe Endometriosis Therapies Forecast by Country (2024-2029)
10.4.1 Germany Endometriosis Therapies Market Forecast
10.4.2 France Endometriosis Therapies Market Forecast
10.4.3 UK Endometriosis Therapies Market Forecast
10.4.4 Italy Endometriosis Therapies Market Forecast
10.4.5 Russia Endometriosis Therapies Market Forecast
10.5 Middle East & Africa Endometriosis Therapies Forecast by Region (2024-2029)
10.5.1 Egypt Endometriosis Therapies Market Forecast
10.5.2 South Africa Endometriosis Therapies Market Forecast
10.5.3 Israel Endometriosis Therapies Market Forecast
10.5.4 Turkey Endometriosis Therapies Market Forecast
10.5.5 GCC Countries Endometriosis Therapies Market Forecast
10.6 Global Endometriosis Therapies Forecast by Type (2024-2029)
10.7 Global Endometriosis Therapies Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Endometriosis Therapies Product Offered
11.1.3 AbbVie Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Information
11.2.2 Eli Lilly Endometriosis Therapies Product Offered
11.2.3 Eli Lilly Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Eli Lilly Main Business Overview
11.2.5 Eli Lilly Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Endometriosis Therapies Product Offered
11.3.3 AstraZeneca Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Endometriosis Therapies Product Offered
11.4.3 Bayer Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 Astellas Pharma
11.5.1 Astellas Pharma Company Information
11.5.2 Astellas Pharma Endometriosis Therapies Product Offered
11.5.3 Astellas Pharma Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Astellas Pharma Main Business Overview
11.5.5 Astellas Pharma Latest Developments
11.6 Meditrina Pharmaceuticals
11.6.1 Meditrina Pharmaceuticals Company Information
11.6.2 Meditrina Pharmaceuticals Endometriosis Therapies Product Offered
11.6.3 Meditrina Pharmaceuticals Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Meditrina Pharmaceuticals Main Business Overview
11.6.5 Meditrina Pharmaceuticals Latest Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer Endometriosis Therapies Product Offered
11.7.3 Pfizer Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Pfizer Main Business Overview
11.7.5 Pfizer Latest Developments
11.8 Neurocrine Biosciences
11.8.1 Neurocrine Biosciences Company Information
11.8.2 Neurocrine Biosciences Endometriosis Therapies Product Offered
11.8.3 Neurocrine Biosciences Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Neurocrine Biosciences Main Business Overview
11.8.5 Neurocrine Biosciences Latest Developments
11.9 Takeda Pharmaceutical
11.9.1 Takeda Pharmaceutical Company Information
11.9.2 Takeda Pharmaceutical Endometriosis Therapies Product Offered
11.9.3 Takeda Pharmaceutical Endometriosis Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Takeda Pharmaceutical Main Business Overview
11.9.5 Takeda Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Endometriosis Therapies Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Hormonal Contraceptives
Table 3. Major Players of Gonadotropin-releasingHormone(Gn-RH)Agonists
Table 4. Major Players of Progestin Therapy
Table 5. Major Players of Aromatase Inhibitors
Table 6. Endometriosis Therapies Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Endometriosis Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Endometriosis Therapies Market Size Market Share by Type (2018-2023)
Table 9. Endometriosis Therapies Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Endometriosis Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Endometriosis Therapies Market Size Market Share by Application (2018-2023)
Table 12. Global Endometriosis Therapies Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Endometriosis Therapies Revenue Market Share by Player (2018-2023)
Table 14. Endometriosis Therapies Key Players Head office and Products Offered
Table 15. Endometriosis Therapies Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Endometriosis Therapies Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Endometriosis Therapies Market Size Market Share by Regions (2018-2023)
Table 20. Global Endometriosis Therapies Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Endometriosis Therapies Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Endometriosis Therapies Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Endometriosis Therapies Market Size Market Share by Country (2018-2023)
Table 24. Americas Endometriosis Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Endometriosis Therapies Market Size Market Share by Type (2018-2023)
Table 26. Americas Endometriosis Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Endometriosis Therapies Market Size Market Share by Application (2018-2023)
Table 28. APAC Endometriosis Therapies Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Endometriosis Therapies Market Size Market Share by Region (2018-2023)
Table 30. APAC Endometriosis Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Endometriosis Therapies Market Size Market Share by Type (2018-2023)
Table 32. APAC Endometriosis Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Endometriosis Therapies Market Size Market Share by Application (2018-2023)
Table 34. Europe Endometriosis Therapies Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Endometriosis Therapies Market Size Market Share by Country (2018-2023)
Table 36. Europe Endometriosis Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Endometriosis Therapies Market Size Market Share by Type (2018-2023)
Table 38. Europe Endometriosis Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Endometriosis Therapies Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Endometriosis Therapies Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Endometriosis Therapies Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Endometriosis Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Endometriosis Therapies Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Endometriosis Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Endometriosis Therapies Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Endometriosis Therapies
Table 47. Key Market Challenges & Risks of Endometriosis Therapies
Table 48. Key Industry Trends of Endometriosis Therapies
Table 49. Global Endometriosis Therapies Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Endometriosis Therapies Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Endometriosis Therapies Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Endometriosis Therapies Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. AbbVie Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 54. AbbVie Endometriosis Therapies Product Offered
Table 55. AbbVie Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. AbbVie Main Business
Table 57. AbbVie Latest Developments
Table 58. Eli Lilly Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 59. Eli Lilly Endometriosis Therapies Product Offered
Table 60. Eli Lilly Main Business
Table 61. Eli Lilly Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Eli Lilly Latest Developments
Table 63. AstraZeneca Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 64. AstraZeneca Endometriosis Therapies Product Offered
Table 65. AstraZeneca Main Business
Table 66. AstraZeneca Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. AstraZeneca Latest Developments
Table 68. Bayer Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 69. Bayer Endometriosis Therapies Product Offered
Table 70. Bayer Main Business
Table 71. Bayer Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Bayer Latest Developments
Table 73. Astellas Pharma Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 74. Astellas Pharma Endometriosis Therapies Product Offered
Table 75. Astellas Pharma Main Business
Table 76. Astellas Pharma Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Astellas Pharma Latest Developments
Table 78. Meditrina Pharmaceuticals Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 79. Meditrina Pharmaceuticals Endometriosis Therapies Product Offered
Table 80. Meditrina Pharmaceuticals Main Business
Table 81. Meditrina Pharmaceuticals Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Meditrina Pharmaceuticals Latest Developments
Table 83. Pfizer Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 84. Pfizer Endometriosis Therapies Product Offered
Table 85. Pfizer Main Business
Table 86. Pfizer Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Pfizer Latest Developments
Table 88. Neurocrine Biosciences Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 89. Neurocrine Biosciences Endometriosis Therapies Product Offered
Table 90. Neurocrine Biosciences Main Business
Table 91. Neurocrine Biosciences Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Neurocrine Biosciences Latest Developments
Table 93. Takeda Pharmaceutical Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 94. Takeda Pharmaceutical Endometriosis Therapies Product Offered
Table 95. Takeda Pharmaceutical Main Business
Table 96. Takeda Pharmaceutical Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Takeda Pharmaceutical Latest Developments
Table 1. Endometriosis Therapies Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Hormonal Contraceptives
Table 3. Major Players of Gonadotropin-releasingHormone(Gn-RH)Agonists
Table 4. Major Players of Progestin Therapy
Table 5. Major Players of Aromatase Inhibitors
Table 6. Endometriosis Therapies Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Endometriosis Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Endometriosis Therapies Market Size Market Share by Type (2018-2023)
Table 9. Endometriosis Therapies Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Endometriosis Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Endometriosis Therapies Market Size Market Share by Application (2018-2023)
Table 12. Global Endometriosis Therapies Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Endometriosis Therapies Revenue Market Share by Player (2018-2023)
Table 14. Endometriosis Therapies Key Players Head office and Products Offered
Table 15. Endometriosis Therapies Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Endometriosis Therapies Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Endometriosis Therapies Market Size Market Share by Regions (2018-2023)
Table 20. Global Endometriosis Therapies Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Endometriosis Therapies Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Endometriosis Therapies Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Endometriosis Therapies Market Size Market Share by Country (2018-2023)
Table 24. Americas Endometriosis Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Endometriosis Therapies Market Size Market Share by Type (2018-2023)
Table 26. Americas Endometriosis Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Endometriosis Therapies Market Size Market Share by Application (2018-2023)
Table 28. APAC Endometriosis Therapies Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Endometriosis Therapies Market Size Market Share by Region (2018-2023)
Table 30. APAC Endometriosis Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Endometriosis Therapies Market Size Market Share by Type (2018-2023)
Table 32. APAC Endometriosis Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Endometriosis Therapies Market Size Market Share by Application (2018-2023)
Table 34. Europe Endometriosis Therapies Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Endometriosis Therapies Market Size Market Share by Country (2018-2023)
Table 36. Europe Endometriosis Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Endometriosis Therapies Market Size Market Share by Type (2018-2023)
Table 38. Europe Endometriosis Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Endometriosis Therapies Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Endometriosis Therapies Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Endometriosis Therapies Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Endometriosis Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Endometriosis Therapies Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Endometriosis Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Endometriosis Therapies Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Endometriosis Therapies
Table 47. Key Market Challenges & Risks of Endometriosis Therapies
Table 48. Key Industry Trends of Endometriosis Therapies
Table 49. Global Endometriosis Therapies Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Endometriosis Therapies Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Endometriosis Therapies Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Endometriosis Therapies Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. AbbVie Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 54. AbbVie Endometriosis Therapies Product Offered
Table 55. AbbVie Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. AbbVie Main Business
Table 57. AbbVie Latest Developments
Table 58. Eli Lilly Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 59. Eli Lilly Endometriosis Therapies Product Offered
Table 60. Eli Lilly Main Business
Table 61. Eli Lilly Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Eli Lilly Latest Developments
Table 63. AstraZeneca Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 64. AstraZeneca Endometriosis Therapies Product Offered
Table 65. AstraZeneca Main Business
Table 66. AstraZeneca Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. AstraZeneca Latest Developments
Table 68. Bayer Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 69. Bayer Endometriosis Therapies Product Offered
Table 70. Bayer Main Business
Table 71. Bayer Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Bayer Latest Developments
Table 73. Astellas Pharma Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 74. Astellas Pharma Endometriosis Therapies Product Offered
Table 75. Astellas Pharma Main Business
Table 76. Astellas Pharma Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Astellas Pharma Latest Developments
Table 78. Meditrina Pharmaceuticals Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 79. Meditrina Pharmaceuticals Endometriosis Therapies Product Offered
Table 80. Meditrina Pharmaceuticals Main Business
Table 81. Meditrina Pharmaceuticals Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Meditrina Pharmaceuticals Latest Developments
Table 83. Pfizer Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 84. Pfizer Endometriosis Therapies Product Offered
Table 85. Pfizer Main Business
Table 86. Pfizer Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Pfizer Latest Developments
Table 88. Neurocrine Biosciences Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 89. Neurocrine Biosciences Endometriosis Therapies Product Offered
Table 90. Neurocrine Biosciences Main Business
Table 91. Neurocrine Biosciences Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Neurocrine Biosciences Latest Developments
Table 93. Takeda Pharmaceutical Details, Company Type, Endometriosis Therapies Area Served and Its Competitors
Table 94. Takeda Pharmaceutical Endometriosis Therapies Product Offered
Table 95. Takeda Pharmaceutical Main Business
Table 96. Takeda Pharmaceutical Endometriosis Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Takeda Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Endometriosis Therapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Endometriosis Therapies Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Endometriosis Therapies Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Endometriosis Therapies Sales Market Share by Country/Region (2022)
Figure 8. Endometriosis Therapies Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Endometriosis Therapies Market Size Market Share by Type in 2022
Figure 10. Endometriosis Therapies in Hospital
Figure 11. Global Endometriosis Therapies Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Endometriosis Therapies in Clinic
Figure 13. Global Endometriosis Therapies Market: Clinic (2018-2023) & ($ Millions)
Figure 14. Endometriosis Therapies in Other
Figure 15. Global Endometriosis Therapies Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Endometriosis Therapies Market Size Market Share by Application in 2022
Figure 17. Global Endometriosis Therapies Revenue Market Share by Player in 2022
Figure 18. Global Endometriosis Therapies Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Endometriosis Therapies Market Size 2018-2023 ($ Millions)
Figure 20. APAC Endometriosis Therapies Market Size 2018-2023 ($ Millions)
Figure 21. Europe Endometriosis Therapies Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Endometriosis Therapies Market Size 2018-2023 ($ Millions)
Figure 23. Americas Endometriosis Therapies Value Market Share by Country in 2022
Figure 24. United States Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Endometriosis Therapies Market Size Market Share by Region in 2022
Figure 29. APAC Endometriosis Therapies Market Size Market Share by Type in 2022
Figure 30. APAC Endometriosis Therapies Market Size Market Share by Application in 2022
Figure 31. China Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Endometriosis Therapies Market Size Market Share by Country in 2022
Figure 38. Europe Endometriosis Therapies Market Size Market Share by Type (2018-2023)
Figure 39. Europe Endometriosis Therapies Market Size Market Share by Application (2018-2023)
Figure 40. Germany Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Endometriosis Therapies Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Endometriosis Therapies Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Endometriosis Therapies Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 54. APAC Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 55. Europe Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 57. United States Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 58. Canada Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 61. China Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 62. Japan Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 63. Korea Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 65. India Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 66. Australia Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 67. Germany Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 68. France Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 69. UK Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 70. Italy Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 71. Russia Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 72. Spain Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 75. Israel Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 78. Global Endometriosis Therapies Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Endometriosis Therapies Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Endometriosis Therapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Endometriosis Therapies Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Endometriosis Therapies Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Endometriosis Therapies Sales Market Share by Country/Region (2022)
Figure 8. Endometriosis Therapies Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Endometriosis Therapies Market Size Market Share by Type in 2022
Figure 10. Endometriosis Therapies in Hospital
Figure 11. Global Endometriosis Therapies Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Endometriosis Therapies in Clinic
Figure 13. Global Endometriosis Therapies Market: Clinic (2018-2023) & ($ Millions)
Figure 14. Endometriosis Therapies in Other
Figure 15. Global Endometriosis Therapies Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Endometriosis Therapies Market Size Market Share by Application in 2022
Figure 17. Global Endometriosis Therapies Revenue Market Share by Player in 2022
Figure 18. Global Endometriosis Therapies Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Endometriosis Therapies Market Size 2018-2023 ($ Millions)
Figure 20. APAC Endometriosis Therapies Market Size 2018-2023 ($ Millions)
Figure 21. Europe Endometriosis Therapies Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Endometriosis Therapies Market Size 2018-2023 ($ Millions)
Figure 23. Americas Endometriosis Therapies Value Market Share by Country in 2022
Figure 24. United States Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Endometriosis Therapies Market Size Market Share by Region in 2022
Figure 29. APAC Endometriosis Therapies Market Size Market Share by Type in 2022
Figure 30. APAC Endometriosis Therapies Market Size Market Share by Application in 2022
Figure 31. China Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Endometriosis Therapies Market Size Market Share by Country in 2022
Figure 38. Europe Endometriosis Therapies Market Size Market Share by Type (2018-2023)
Figure 39. Europe Endometriosis Therapies Market Size Market Share by Application (2018-2023)
Figure 40. Germany Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Endometriosis Therapies Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Endometriosis Therapies Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Endometriosis Therapies Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Endometriosis Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 54. APAC Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 55. Europe Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 57. United States Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 58. Canada Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 61. China Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 62. Japan Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 63. Korea Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 65. India Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 66. Australia Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 67. Germany Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 68. France Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 69. UK Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 70. Italy Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 71. Russia Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 72. Spain Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 75. Israel Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Endometriosis Therapies Market Size 2024-2029 ($ Millions)
Figure 78. Global Endometriosis Therapies Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Endometriosis Therapies Market Size Market Share Forecast by Application (2024-2029)
